Dr. Daniel S. Caplivski, MD

Dr. Caplivski practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Caplivski's NPI, 1649298480, was assigned on July 18, 2006. Dr. Caplivski graduated from Yale School of Medicine in 2000. Dr. Caplivski holds New York license 221805.

Dr. Caplivski's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121. Dr. Caplivski also practices at Mount Sinai Medical Center, 5 E 98th St, New York, NY 10029.

Dr. Caplivski's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. Dr. Caplivski is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Caplivski to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Caplivski practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Caplivski's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Caplivski is licensed in New York.

Dmand AI lists acute skin infection, cold sores or genital herpes, facial skin infection, hiv/aids, joint or bone infection, lyme disease, UTI and yeast infection among the conditions Dr. Caplivski treats.

CMS data shows 822 Medicare services from Dr. Caplivski across 11 procedure codes in 2024, for 390 Medicare patients. Medicare paid $73,276 for them.

CMS counts 390 Medicare patients who saw Dr. Caplivski in 2024. The largest group is 65 to 74, with 157 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Caplivski's median patient age at 46, with 51% women.

In 2024, Dr. Caplivski wrote 991 Medicare Part D claims for 217 patients. 67% of them were for generic drugs. CMS names the drug for 750 of them, across 25 drugs with 11 or more claims each, at $1,012,933 in total drug cost. In 2023, CMS named 629 claims across 25 drugs.

Dr. Caplivski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Caplivski as offering telehealth.

Dmand AI links 21 papers to Dr. Caplivski, published from 2005 to 2021. 2020 was the busiest year, with 4. The most frequent topics are Entamoeba histolytica, Amino Acid Sequence and Antifungal Agents. Dr. Caplivski has published most often in Case Rep Infect Dis. Dr. Caplivski's most frequent co-authors are Deena Rose Altman, MD, Eric Bressman, MD and Daniel Seth Fierer, MD.

CMS Open Payments shows 1 general payment to Dr. Caplivski from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Cumberland Pharmaceuticals, Inc. paid the most, $21.

Dmand AI lists 3 awards for Dr. Caplivski, most recently Top Doctors in 2018.

Dr. Caplivski graduated from Yale School of Medicine in 2000.

Dr. Caplivski is in network with 15 carriers, including Aetna, United Healthcare and HCSC. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.